CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
89 hedge funds and large institutions have $1.68B invested in China Biologic Products Holdings, Inc. in 2020 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 87 → 89 (+2)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
89
Holding in Top 10
6
Calls
$9.45M
Puts
$992K
Top Buyers
| 1 | +$84.3M | |
| 2 | +$63.1M | |
| 3 | +$38.6M | |
| 4 |
Capstone Investment Advisors
New York
|
+$31.4M |
| 5 |
PAM
PSquared Asset Management
Zurich,
Switzerland
|
+$24.2M |
Top Sellers
| 1 | -$136M | |
| 2 | -$39M | |
| 3 | -$30.2M | |
| 4 |
Renaissance Technologies
New York
|
-$25.5M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$20.5M |